Symptomatic Retinal Microangiopathy in a Patient with Coronavirus Disease 2019 (COVID-19): Single Case Report

Julio J Gonzalez-Lopez1, Beatriz Felix Espinar1, Cristina Ye-Zhu1

  • 1Ophthalmology Department, Hospital Universitario Ramon y Cajal, IRYCIS, Madrid, Spain.

Insights

Late-phase Coronavirus Disease 2019 (COVID-19) can cause vision loss from retinal microvascular ischemia. This case highlights potential ocular complications, including visual field defects, during COVID-19 recovery.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Vascular Medicine

Background:

  • Coronavirus Disease 2019 (COVID-19) is linked to ocular manifestations, including conjunctivitis and retinal vascular changes.
  • Retinal microvascular ischemia has been observed in patients with COVID-19, even those asymptomatic.

Observation:

  • A 50-year-old male with COVID-19 pneumonia presented with a left arcuate visual field defect.
  • Funduscopy showed bilateral cotton-wool spots, and OCT-angiography confirmed multifocal retinal microvascular ischemia.

Findings:

  • The patient experienced visual field defects attributed to retinal microangiopathy during the late phase of COVID-19.
  • OCT-angiography findings correlated with the observed visual field deficits.

Implications:

  • Retinal microangiopathy and associated visual field defects can manifest in the late stages of COVID-19.
  • Ocular findings may serve as indicators of systemic vascular changes in less accessible organs due to COVID-19.